Haoyu Lin

1.3k total citations
39 papers, 851 citations indexed

About

Haoyu Lin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Haoyu Lin has authored 39 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Haoyu Lin's work include Cancer Cells and Metastasis (7 papers), Epigenetics and DNA Methylation (6 papers) and Cancer-related molecular mechanisms research (5 papers). Haoyu Lin is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Epigenetics and DNA Methylation (6 papers) and Cancer-related molecular mechanisms research (5 papers). Haoyu Lin collaborates with scholars based in China, Netherlands and Hong Kong. Haoyu Lin's co-authors include De Zeng, Yuanke Liang, Chunfa Chen, Xiaolong Wei, Yingsheng Xiao, Guo‐Jun Zhang, Xiaofeng Lu, Shuming Sun, Jing‐Wen Bai and Min Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Nanoscale.

In The Last Decade

Haoyu Lin

38 papers receiving 836 citations

Peers

Haoyu Lin
Junxin Wu China
Aibing Wu China
Lei Lang China
Chunxia Cao United States
Junxin Wu China
Haoyu Lin
Citations per year, relative to Haoyu Lin Haoyu Lin (= 1×) peers Junxin Wu

Countries citing papers authored by Haoyu Lin

Since Specialization
Citations

This map shows the geographic impact of Haoyu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoyu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoyu Lin more than expected).

Fields of papers citing papers by Haoyu Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoyu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoyu Lin. The network helps show where Haoyu Lin may publish in the future.

Co-authorship network of co-authors of Haoyu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Haoyu Lin. A scholar is included among the top collaborators of Haoyu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoyu Lin. Haoyu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Yuanke, et al.. (2025). Enhancing medical English proficiency: the current status and development potential of peer-assisted learning in medical education. BMC Medical Education. 25(1). 79–79. 1 indexed citations
2.
Chen, Yu‐Cheng, Zhixiang Li, Haoyu Lin, et al.. (2025). Exosomes from human umbilical cord mesenchymal stem cells promote the growth of human hair dermal papilla cells. PLoS ONE. 20(4). e0320154–e0320154. 3 indexed citations
3.
Wang, Shimeng, Guan‐Yuan Chen, Chengyu Wu, et al.. (2024). RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities. Critical Reviews in Oncology/Hematology. 195. 104271–104271. 4 indexed citations
4.
Zheng, Weizhong, Chun‐Peng Liu, Yongqiang Zhao, et al.. (2024). Pan-cancer analysis reveals CCL5/CSF2 as potential predictive biomarkers for immune checkpoint inhibitors. Cancer Cell International. 24(1). 311–311. 1 indexed citations
5.
Song, Xiaolei, Haoyu Lin, Xiaoshuai Wu, et al.. (2024). Conjugate electrospinning of aligned polymer nanofibers at different intersection angles between the oppositely charged spinning nozzles. Journal of Nanoparticle Research. 26(7). 1 indexed citations
7.
Huang, Xiujie, et al.. (2024). Performance of ChatGPT and Bard on the medical licensing examinations varies across different cultures: a comparison study. BMC Medical Education. 24(1). 1372–1372. 12 indexed citations
8.
Liang, Yuanke, Jinxing Liu, Kaiyuan Huang, et al.. (2023). HER2-targeting two-dimensional black phosphorus as a nanoplatform for chemo-photothermal therapy in breast cancer. Materials Today Bio. 23. 100812–100812. 6 indexed citations
9.
Lau, Joseph T. F., et al.. (2023). Prevalence and factors of COVID-19 vaccine refusal among solid cancer patients in China: an application of the health belief model. Frontiers in Public Health. 11. 1236376–1236376. 1 indexed citations
10.
Wang, Kun, Yanxia Shi, Yuanqi Zhang, et al.. (2022). Markers Associated With Tumor Recurrence in Patients With Breast Cancer Achieving a Pathologic Complete Response After Neoadjuvant Chemotherapy. Frontiers in Oncology. 12. 860475–860475. 6 indexed citations
11.
Liang, Yuanke, Xiaoling Zhou, Qin Xie, et al.. (2022). CD146 interaction with integrin β1 activates LATS1-YAP signaling and induces radiation-resistance in breast cancer cells. Cancer Letters. 546. 215856–215856. 23 indexed citations
12.
Liang, Yuanke, Judith T.M.L. Paridaen, Nynke Oosterhof, et al.. (2022). CD146 increases stemness and aggressiveness in glioblastoma and activates YAP signaling. Cellular and Molecular Life Sciences. 79(8). 398–398. 27 indexed citations
13.
Zhang, Yong‐Qu, Yuanke Liang, Yang Wu, et al.. (2021). Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN. Cell Death and Disease. 12(6). 502–502. 34 indexed citations
14.
Liang, Yuanke, Si-Qi Qiu, Yingsheng Xiao, et al.. (2021). CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer. Frontiers in Oncology. 11. 710286–710286. 40 indexed citations
15.
Xie, Qin, Yingsheng Xiao, Yi‐Chun Chen, et al.. (2020). FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer. Cancer Cell International. 20(1). 562–562. 16 indexed citations
16.
Zeng, De, Haoyu Lin, Yuling Zhang, et al.. (2020). A negative binomial regression model for risk estimation of 0–2 axillary lymph node metastases in breast cancer patients. Scientific Reports. 10(1). 21856–21856. 3 indexed citations
17.
Zeng, De, Chunfa Chen, Shuming Sun, et al.. (2019). <p><em>Long noncoding RNA H19</em> is a critical oncogenic driver and contributes to epithelial-mesenchymal transition in papillary thyroid carcinoma</p>. Cancer Management and Research. Volume 11. 2059–2072. 26 indexed citations
18.
Chen, Chunfa, Yuling Zhang, Shuming Sun, et al.. (2019). Predictive Value of Preoperative Multidetector-Row Computed Tomography for Axillary Lymph Nodes Metastasis in Patients With Breast Cancer. Frontiers in Oncology. 8. 666–666. 23 indexed citations
19.
Li, Meifang, Min Chen, Zun Wang, et al.. (2019). GATA Binding Protein 3 Boosts Extracellular ATP Hydrolysis and Inhibits Metastasis of Breast Cancer by Up-regulating Ectonucleoside Triphosphate Diphosphohydrolase 3. International Journal of Biological Sciences. 15(12). 2522–2537. 8 indexed citations
20.
Dou, Xiaowei, Yuanke Liang, Haoyu Lin, et al.. (2017). Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α. Theranostics. 7(16). 4041–4056. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026